Mark Lamberti has established himself as a formidable figure in the South African business landscape. With a career spanning several decades, his name is synonymous
Month: September 2024
Anavex Life Sciences has released encouraging preliminary data from its 48-week open-label extension Phase 2 study of ANAVEX®2-73 (blarcamesine) in patients with Parkinson’s disease dementia.